Amin Sobh

655 total citations
25 papers, 355 citations indexed

About

Amin Sobh is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, Amin Sobh has authored 25 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Hematology and 3 papers in Infectious Diseases. Recurrent topics in Amin Sobh's work include CRISPR and Genetic Engineering (9 papers), Protein Degradation and Inhibitors (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Amin Sobh is often cited by papers focused on CRISPR and Genetic Engineering (9 papers), Protein Degradation and Inhibitors (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Amin Sobh collaborates with scholars based in United States, Russia and Spain. Amin Sobh's co-authors include Chris D. Vulpe, Abderrahmane Tagmount, Jonathan D. Licht, Luoping Zhang, Guangrong Zheng, Daohong Zhou, Xuan Zhang, Alex Loguinov, Alan Hubbard and Qingping Yang and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Analytical Chemistry.

In The Last Decade

Amin Sobh

24 papers receiving 353 citations

Peers

Countries citing papers authored by Amin Sobh

Since Specialization

Citations

This map shows the geographic impact of Amin Sobh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amin Sobh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amin Sobh more than expected).

Fields of papers citing papers by Amin Sobh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amin Sobh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amin Sobh. The network helps show where Amin Sobh may publish in the future.

Co-authorship network of co-authors of Amin Sobh

This figure shows the co-authorship network connecting the top 25 collaborators of Amin Sobh. A scholar is included among the top collaborators of Amin Sobh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amin Sobh. Amin Sobh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	KDM6A regulates immune response genes in multiple myeloma 2024 ·Blood ·(unknown), Alberto Riva, Benjamin G. Barwick, Sayantan Maji, (unknown), Jianping Li, Umasankar De, Amin Sobh, (unknown), (unknown), Marta Kulis, Teresa Ezponda, José I. Martı́n-Subero, Giovanni Tonon, Weizhou Zhang, Constantine S. Mitsiades, Lawrence Boise, Richard L. Bennett, Jonathan D. Licht	5
2	Iron and cancer: overview of the evidence from population-based studies 2024 ·Frontiers in Oncology ·(unknown), Hyung‐Suk Yoon, (unknown), Amin Sobh, Dejana Braithwaite, Robert T. Mankowski, Christiaan Leeuwenburgh, (unknown)	4
3	Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2 2023 ·Journal of the American Chemical Society ·Ronan P. Hanley, Yan Nie, (unknown), Fengling Li, Amin Sobh, Chenxi Xu, Natalie K. Barker, David Dilworth, Taraneh Hajian, Elisa Gibson, Magdalena M. Szewczyk, Peter J. Brown, Dalia Baršytė-Lovejoy, Laura E. Herring, Gang Greg Wang, Jonathan D. Licht, Masoud Vedadi, C.H. Arrowsmith, Lindsey I. James	32
4	Piperlongumine conjugates induce targeted protein degradation 2023 ·Cell chemical biology ·Jing Pei, Yufeng Xiao, Xingui Liu, Wanyi Hu, Amin Sobh, Yaxia Yuan, Shuo Zhou, Nan Hua, Samuel G. Mackintosh, Xuan Zhang, Kari B. Basso, (unknown), Qingping Yang, Jonathan D. Licht, Guangrong Zheng, Daohong Zhou, Dongwen Lv	48
5	Activating NSD2 Mutations Drive Oncogenic Reprogramming By Disturbing Epigenetic Landscape in Mantle Cell Lymphoma 2023 ·Blood ·Jianping Li, Marta Kulis, Alberto Riva, (unknown), Daphné Dupéré-Richer, (unknown), (unknown), (unknown), (unknown), Amin Sobh, (unknown), Richard L. Bennett, (unknown), Jonathan D. Licht	1
6	Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML 2022 ·Blood Advances ·(unknown), (unknown), Abderrahmane Tagmount, Amin Sobh, (unknown), (unknown), Abdelrahman H. Elsayed, (unknown), Nathan D. Seligson, Christopher R. Cogle, Jeffrey E. Rubnitz, Raul C. Ribeiro, James R. Downing, Xueyuan Cao, Stanley Pounds, Chris D. Vulpe, Jatinder K. Lamba	9
7	Genome-scale CRISPR screens identify host factors that promote human coronavirus infection 2022 ·Genome Medicine ·(unknown), Andrew P. Bluhm, (unknown), Abderrahmane Tagmount, (unknown), Amin Sobh, (unknown), Chris D. Vulpe, Stephanie M. Karst, Michael H. Norris	27
8	Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL–Specific Degrader DT2216 2021 ·Molecular Cancer Therapeutics ·Dinesh Thummuri, Sajid Khan, Patrick W. Underwood, Peiyi Zhang, J Wiegand, Xuan Zhang, Vivekananda Budamagunta, Amin Sobh, Abderrahmane Tagmount, (unknown), Andrea N. Riner, Ashwin Akki, Elizabeth A. Williamson, Robert Hromas, Chris D. Vulpe, Guangrong Zheng, José G. Treviño, Daohong Zhou	51
9	Separation and Characterization of Endogenous Nucleosomes by Native Capillary Zone Electrophoresis–Top-Down Mass Spectrometry 2021 ·Analytical Chemistry ·Kevin Jooß, Luis F. Schachner, Rachel Watson, (unknown), Sarah A. Howard, Marcus A. Cheek, Matthew J. Meiners, Amin Sobh, Jonathan D. Licht, Michael‐Christopher Keogh, Neil L. Kelleher	23
10	CRISPR Screens in Toxicology Research: An Overview 2021 ·Current Protocols ·Amin Sobh, (unknown), Chris D. Vulpe	6
11	Dysregulation of Epigenetic Landscape Uncovered the Mechanisms Underlying the Relapse of Pediatric Acute Lymphoblastic Leukemia with NSD2 Mutation 2021 ·Blood ·Jianping Li, Priscillia Lhoumaud, Alberto Riva, (unknown), Daphné Dupéré-Richer, (unknown), Amin Sobh, (unknown), Alok Swaroop, Marta Kulis, Richard L. Bennett, Jane A. Skok, Jonathan D. Licht	1
12	Applying genome-wide CRISPR to identify known and novel genes and pathways that modulate formaldehyde toxicity 2020 ·Chemosphere ·Yun Zhao, (unknown), Abderrahmane Tagmount, Alex Loguinov, Amin Sobh, Alan Hubbard, Cliona M. McHale, Christopher J. Chang, Chris D. Vulpe, Luoping Zhang	22
13	Functional Pathway Identification With CRISPR/Cas9 Genome-wide Gene Disruption in Human Dopaminergic Neuronal Cells Following Chronic Treatment With Dieldrin 2020 ·Toxicological Sciences ·(unknown), Amin Sobh, Ping Zhang, Alex Loguinov, Abderrahmane Tagmount, Chris D. Vulpe, Bin Liu	13
14	Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde 2019 ·Toxicological Sciences ·Amin Sobh, (unknown), Alessia Stornetta, Silvia Balbo, Abderrahmane Tagmount, Luoping Zhang, Chris D. Vulpe	15
15	<em>HOX</em> Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries 2019 ·Journal of Visualized Experiments ·Huacheng Luo, Amin Sobh, Chris D. Vulpe, Edmond D Brewer, Sinisa Dovat, Yi Qiu, Suming Huang	2
16	Identification of Genetic Vulnerabilities and Synthetic-Lethal Targets in NSD2-High Multiple Myeloma 2019 ·Blood ·Amin Sobh, (unknown), Alberto Riva, Jonathan D. Licht	1
17	CRISPR Dropout Screens Identify DHODH,PIK3C3, and Crkl as Potential Therapeutic Targets in Acute Myeloid Leukemia 2019 ·Blood ·(unknown), Yujia Zhou, David King, Amy Meacham, (unknown), Abderrahmane Tagmount, Amin Sobh, (unknown), Chris D. Vulpe, Christopher R. Cogle	2
18	Genome-Scale CRISPR-Cas9 Synthetic Lethal Screening of AML Cell Line Identified Functional Modulators of Etoposide Resistance Predictive of Clinical Outcome in AML Patients 2019 ·Blood ·(unknown), Amin Sobh, Abdelrahman H. Elsayed, Abderrahmane Tagmount, Chris D. Vulpe, Jatinder K. Lamba	3
19	Functional Profiling Identifies Determinants of Arsenic Trioxide Cellular Toxicity 2019 ·Toxicological Sciences ·Amin Sobh, (unknown), Gülce Naz Yazıcı, (unknown), Abderrahmane Tagmount, Nima S. Hejazi, Alan Hubbard, Luoping Zhang, Chris D. Vulpe	24
20	CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia 2018 ·Blood ·Huacheng Luo, Fei Wang, Jie Zha, (unknown), Bowen Yan, (unknown), Feng‐Chun Yang, Amin Sobh, Chris D. Vulpe, Leylah Drusbosky, Christopher R. Cogle, Iouri Chepelev, Bing Xu, Stephen D. Nimer, Jonathan D. Licht, Yi Qiu, Baoan Chen, Mingjiang Xu, Suming Huang	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact